|
1
|
Rachata N: Determining significant risk
factors for cardiovascular complications of patient with type 2
diabetes mellitus and hypertension using multi-expert
multi-criteria decision making. 2021 Joint International Conference
on DAMT with ECTI NCON, Cha-Am, Thailand: 202-205, 2021.
|
|
2
|
Taheri M, Eghtedarian R, Ghafouri-Fard S
and Omrani MD: Non-coding RNAs and type 2 diabetes mellitus. Arch
Physiol Biochem. 6:1–10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
The Lancet: Diabetes: A dynamic disease.
Lancet. 389(2163)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Iminger-Finger I, Kargul J and Laurent GJ:
Diabetes: Present and future. Int J Biochem Cell Biol.
88(196)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cirillo E, Kutmon M, Hernandez MG,
Hooimeijer T, Adriaens ME, Eijssen LMT, Parnell LD, Coort SL and
Evelo CT: From SNPs to pathways: Biological interpretation of type
2 diabetes (T2DM) genome wide association study (GWAS) results.
PLoS One. 13(e0193515)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jakubik D, Fitas A, Eyileten C,
Jarosz-Popek J, Nowak A, Czajka P, Wicik Z, Sorij H, Siller-Matula
JM, De Rosa S and Postula M: MicroRNAs and long non-coding RNAs in
the pathophysiological processes of diabetic cardiomyopathy:
Emerging biomarkers and potential therapeutics. Cardiovasc
Diabetol. 20(55)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kurkewich JL, Hansen J, Klopfenstein N,
Zhang H, Wood C, Boucher A, Hickman J, Muench DE, Grimes HL and
Dahl R: The miR-23a~27a~24-2 microRNA cluster buffers transcription
and signaling pathways during hematopoiesis. PLoS Genet.
13(e1006887)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ji C, Xu QH, Guo LC, Wang XH, Ren YJ,
Zhang HH, Zhu WD, Ming ZJ, Yuan YS, Ren XC, et al: eEF-2
Kinase-targeted miR-449b confers radiation sensitivity to cancer
cells. Cancer Lett. 418:64–74. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rah HC, Chung KW, Ko KH, Kim ES, Kim JO,
Sakong JH, Kim JH, Lee WS and Kim NK: miR-27a and miR-449b
polymorphisms associated with a risk of idiopathic recurrent
pregnancy loss. PLoS One. 12(e0177160)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mott JL and Mohr AM: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ghaedi H, Tabasinezhad M, Alipoor B,
Shokri F, Movafagh A, Mirfakhraie R, Omrani MD and Masotti A: The
pre-mir-27a variant rs895819 may contribute to type 2 diabetes
mellitus susceptibility in an Iranian cohort. J Endocrinol Invest.
39:1187–1193. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pheiffer C, Dias S, Rheeder P and Adam S:
Decreased expression of circulating miR-20a-5p in south African
women with gestational diabetes mellitus. Mol Diagn Ther.
22:345–352. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu Y, Chen J, Zhu X, Tang L, Luo X and
Shi Y: Role of miR-449b-3p in endometriosis via effects on
endometrial stromal cell proliferation and angiogenesis. Mol Med
Rep. 18:3359–365. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang S, Wang B, Xiao H, Dong J, Li Y, Zhu
C, Jin Y, Li H, Cui M and Fan S: LncRNA HOTAIR enhances breast
cancer radioresistance through facilitating HSPA1A expression via
sequestering miR-449b-5p. Thorac Cancer. 11:1801–1816.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gong W, Xiao D, Ming G, Yin J, Zhou H and
Liu Z: Type 2 diabetes mellitus-related genetic polymorphisms in
microRNAs and microRNA target sites. J Diabetes. 6:279–289.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li X, Jia Z, Zhao X, Xu M and Chen M:
Expression of miR-210 in the peripheral blood of patients with
newly diagnosed type 2 diabetes mellitus and its effect on the
number and function of endothelial progenitor cells. Microvasc Res.
131:1–10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang Y, Yang LZ, Yang DG, Zhang QY, Deng
ZN, Wang K and Mao XJ: MiR-21 antagomir improves insulin resistance
and lipid metabolism disorder in streptozotocin-induced type 2
diabetes mellitus rats. Ann Palliat Med. 9:394–404. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ye D, Zhang T, Lou G, Xu W, Dong F, Chen G
and Liu Y: Plasma miR-17, miR-20a, miR-20b and miR-122 as potential
biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus
patients. Life Sci. 208:201–207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Valmadrid CT, Klein R, Moss SE and Klein
BE: The risk of cardiovascular disease mortality associated with
micro-albuminuria and gross proteinuria in persons with older-onset
diabetes mellitus. Arch Intern Med. 160:1093–1100. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kumar R, Nandhini LP, Kamalanathan S,
Sahoo SJ and Vivekanadan M: Evidence for current diagnostic
criteria of diabetes mellitus. World J Diabetes. 7:396–405.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kang SH, Kim YR and Hong SH: Synergy
effects of the ApoC3 and ApoA4 polymorphisms on the risk of
hypertension. Genes Genomics. 39:1163–1172. 2017.
|
|
22
|
Wang TT, Chen YJ, Sun LL, Zhang SJ, Zhou
ZY and Qiao H: Affection of single-nucleotide polymorphisms in
miR-27a, miR-124a, and miR-146a on susceptibility to type 2
diabetes mellitus in Chinese Han people. Chin Med J. 128:533–539.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen X, Wang W, Li R, Yu J and Gao L:
Association between polymorphisms in microRNAs and susceptibility
to diabetes mellitus: A meta-analysis. Medicine.
98(e17519)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim YR and Hong SH: Association between
the polymorphisms of the vascular endothelial growth factor gene
and metabolic syndrome. Biomed Rep. 3:319–326. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Joladarashi D and Krishnamurthy P:
Assessment of miRNA regulation of endothelial progenitor cell
mediated angiogenesis. Methods Mol Biol. 1553:305–314.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ciccacci C, Di Fusco D, Cacciotti L,
Morganti R, D'Amato C, Greco C, Rufini S, Novelli G, Sangiuolo F,
Spallone V and Borgiani P: MicroRNA genetic variations: Association
with type 2 diabetes. Acta Diabetol. 50:867–872. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen T, Zhang Y, Liu Y, Zhu D, Yu J, Li G,
Sun Z, Wang W, Jiang H and Hong Z: MiR-27a promotes insulin
resistance and mediates glucose metabolism by targeting
PPAR-γ-mediated PI3K/AKT signaling. Aging. 11:7510–7524.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Song B, Yan G, Hao H and Yang B:
rs11671784 G/A and rs895819 A/G polymorphisms inversely affect
gastric cancer susceptibility and miR-27a expression in a Chinese
population. Med Sci Monit. 20:2318–2326. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhu Z, Zhang Y, Bai R, Yang R, Shan Z, Ma
C, Yang J and Sun D: Association of genetic polymorphisms in
microRNAs with type 2 diabetes mellitus in a Chinese population.
Front Endocrinol (Lausanne). 11(587561)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kim YR and Hong SH: The protective effects
of the VEGF-2578C>A and -1154G>A polymorphisms against
hypertension susceptibility. Genet Test Mol Biomarkers. 19:476–480.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Goda N, Murase H, Kasezawa N, Goda T and
Yamakawa-Kobayashi K: Polymorphism in microRNA-binding site in
HNF1B influences the susceptibility of type 2 diabetes mellitus: A
population based case-control study. BMC Med Genet. 16:75–83.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Karolina DS, Tavintharan S, Armugam A,
Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF and Jeyaseelan K:
Circulating miRNA profiles in patients with metabolic syndrome. J
Clin Endocrinol Metab. 97:E2271–E2276. 2012.PubMed/NCBI View Article : Google Scholar
|
